Healthy adult
Conditions
Interventions
Intake of ONO-SR/PS, recommended daily intake, for 4 weeks
Intake of ONO-SR/PS 2-fold quantity of recommended daily intake, for 4 weeks
Sponsors
EP Mediate Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Healthy males and females from 20 to 64 years of age (2)BMI 18 or more and less than 25
Exclusion criteria
Exclusion criteria: (1)Subjects who constantly use health food richly containing DHA, EPA, astaxanthin and shark liver oil involvement ingredient more than 1 times a week (2)Subjects who having habit of fish and selfish (including fish roe) more than 4 times a week (3)Subjects having possibilities for emerging allergy related to the study (e.g., fish, prawns, crab and spawn) (4)Subjects who having skin disease, sensitive skin on the upper arm or serious diseases for which medication was required (5)Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (6)Subjects who have diseases that require constant me dication, or who have a history of serious diseases that required medication treatment except dry eye and cavity protection (7) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (8)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (9)Subjects judged as unsuitable for the study based on the results of clinical examination or cardiopulmonary abnormality in the past (10)Subjects who are participating in other clinical research at the start of this study (11)Subjects who intend to become pregnant or lactating (12)Subjects judged as unsuitable for the study by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematologic test, Blood biochemistry test, Urine test, Blood pressure/pulsation, Weight/body mass index, Medical Interview, before and 4 weeks after intake and 2 weeks after the end of intake period and Adverse events thorough the study | — |
Countries
Japan
Contacts
Public ContactTamaki Furuhata
EP Mediate Co., Ltd. Foods Department, Trial Planning Section
Outcome results
None listed